Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors.
Circ Cardiovasc Qual Outcomes
; 10(1)2017 01.
Article
in En
| MEDLINE
| ID: mdl-28073851
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Serine Proteinase Inhibitors
/
Cognition
/
Cognition Disorders
/
Stroke
/
Dyslipidemias
/
PCSK9 Inhibitors
/
Lipids
/
Hypolipidemic Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Circ Cardiovasc Qual Outcomes
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
Year:
2017
Document type:
Article
Country of publication:
United States